IFITM3缺陷小鼠作为肌内途径流感病毒疫苗测试模型
研究探讨缺乏干扰素诱导跨膜蛋白3(IFITM3)的小鼠是否可作为流感疫苗临床前测试模型,观察到多种流感病毒株在IFITM3敲除小鼠中复制增强。IFITM3敲除小鼠对肌内接种疫苗的抗体应答减弱,但加强剂量可提高应答;其针对既往感染和接种的适应性免疫应答在攻毒研究中能限制体重下降、生存和病毒复制。
要点
- IFITM3敲除小鼠中多种流感病毒株复制增强。
- IFITM3敲除小鼠对肌内疫苗的抗体应答减弱,加强剂量可提高。
- 攻毒研究中IFITM3敲除小鼠的适应性免疫应答能限制体重下降、生存和病毒复制。
核心结论
- IFITM3敲除小鼠是一种易得且功能免疫正常的流感疫苗评估临床前模型。
研究设计与样本
- 研究使用缺乏干扰素诱导跨膜蛋白3(IFITM3)的小鼠进行流感病毒疫苗临床前测试。
主要发现
- IFITM3敲除小鼠中多种流感病毒株复制增强。
- IFITM3敲除小鼠对肌内疫苗接种的抗体应答减弱,加强剂量可提高该应答。
- 攻毒研究中,IFITM3敲除小鼠针对既往感染和接种的适应性免疫应答能限制体重下降、生存和病毒复制。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza virus infections remain a significant global health concern. Development of a universal influenza vaccine has been met with challenges, in part due to difficulties with preclinical vaccine testing in mice, which are widely available but are often poorly infected with human and avian influenza viruses. Here, we investigate whether mice lacking interferon-induced transmembrane protein 3 (IFITM3), an antiviral restriction factor, provide a suitable preclinical model for vaccine testing since we observe enhanced replication of multiple influenza virus strains in these mice. We find that IFITM3 KO mice produce a blunted antibody response to intramuscular vaccination that is increased by a booster dose. Nonetheless, their adaptive immune responses to previous infections and vaccinations were found to be functional in limiting weight loss, survival, and viral replication in challenge studies. Overall, our findings identify IFITM3 KO mice as an accessible, functionally immunocompetent preclinical model for assessment of influenza vaccines.
引用
- Eddy AC, Speaks S, Roth M, et al. IFITM3-deficient mice as a model for testing influenza virus vaccines via the intramuscular route. Vaccine. 2025. PMID: 40633129. doi:10.1016/j.vaccine.2025.127458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。